Colucid Pharmaceuticals, Inc.
SEC CIK 1348649 · CLCD · last insider filing 2017-03-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Pappas Arthur M | Director | filed 2015 - 2017 |
| Corrigan Mark | Director | filed 2015 - 2017 |
| White Marvin L | Director | filed 2015 - 2017 |
| Lawton Alison Frances | Director | filed 2016 - 2017 |
| Marengere Luc | Director | filed 2015 - 2017 |
| Mathers Thomas P. | Director · Chief Executive Officer | filed 2015 - 2017 |
| Treu Jesse I | Director | filed 2015 - 2016 |
| DP VI Associates, L.P. | Director | filed 2015 - 2016 |
| Markham Richard J | Director | filed 2015 - 2015 |
| Edwards Martin | Director | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Dallas Matthew D | Chief Financial Officer | filed 2015 - 2017 |
| Hogan Linda C. | VP-Business Development | filed 2015 - 2017 |
| Kuca Bernice | VP-Clin. and Reg. Operations | filed 2015 - 2017 |
| Skwierczynski Raymond | Head,Pharmaceutical Operations | filed 2015 - 2017 |
| Rupniak Nadia | VP-Research and Development | filed 2015 - 2015 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.